We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

ELEKTA

Elekta develops tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well a... read more Featured Products: More products

Download Mobile App




Leading US Cancer Center Signs deal to Acquire Multiple Radiotherapy Solutions

By HospiMedica International staff writers
Posted on 11 May 2016
A US technology leader in cancer management has signed a deal to acquire four HDR brachytherapy afterloaders, an Oncology Information System (OIS), active breathing coordinator, comprehensive treatment planning software, and service for both hardware and software.

The internationally recognized cancer center provides cancer care at various locations in the US state of Texas, and collaborates with community hospitals and health systems across the US.

The MD Anderson Cancer Center (Houston, Texas, USA) will acquire Elekta’s (Stockholm, Sweden) Infinity comprehensive image-guided radiation therapy system with Volumetric Modulated Arc Therapy (VMAT). More...
The deal includes High-Dose-Rate (HDR) afterloaders, Oncentra Brachy treatment planning, the MOSAIQ OIS, and the Active Breathing Coordinator.

Elekta is a human care company that develops tools and treatment planning systems for radiation therapy, radiosurgery, brachytherapy, and brain disorders, as well as workflow enhancement software for cancer care. Elekta will book the new order in the fourth quarter of fiscal year 2015-16.

Bill Yaeger, executive VP, North America region at Elekta, said, “As a world-renowned cancer center, MD Anderson has been a technology leader in managing the disease. In addition to being one of the first U.S. medical centers to acquire Elekta’s new Leksell Gamma Knife Icon brain radiosurgery system, MD Anderson is also part of the consortium to develop the world’s first high-field MR-guided linear accelerator. We are proud that it has chosen us again in the expansion of its facilities in Texas. Both organizations share a commitment to quality and the best care possible for patients.”

Related Links:
MD Anderson Cancer Center
Elekta

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Silver Member
ECG Management System
NEMS Web
External Defibrillator
HeartSave Y | YA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.